SCHEMBL4384670

SCHEMBL4384670

OC(=S)Nn1cnc2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.56
ALOX15 P16050 1/20 0.56
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
HTT P42858 2/20 0.46
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA3 P07451 2/20 0.43
CA4 P22748 2/20 0.43
CA6 P23280 2/20 0.43
CA5A P35218 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
CA13 Q8N1Q1 2/20 0.43
CA14 Q9ULX7 2/20 0.43
CA5B Q9Y2D0 2/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11025532 0.84 ALOX15 (0.51) HSD17B10ALOX15CYP1A2CYP3A4CYP2D6
SCHEMBL204727 0.82 ALOX15 (0.64) HSD17B10ALOX15CYP1A2CYP3A4CYP2D6
SCHEMBL6954737 0.77 ALOX15 (0.58) HSD17B10ALOX15CYP1A2CYP3A4CYP2D6
SCHEMBL4447451 0.77 ALOX15 (0.51) HSD17B10ALOX15CYP1A2CYP3A4CYP2D6
SCHEMBL707209 0.77 ALOX15 (0.58) HSD17B10ALOX15CYP1A2CYP3A4CYP2D6
SCHEMBL15022038 0.77 TDP1 (0.52) HSD17B10ALOX15CYP1A2CYP3A4CYP2D6
SCHEMBL1685055 0.76 HSD17B10 (0.61) HSD17B10ALOX15CYP1A2CYP3A4CYP2D6
SCHEMBL29833600 0.76 SMN1; SMN2 (0.56) HSD17B10HTTTDP1TNFCYP11B1
SCHEMBL29833599 0.76 SMN1; SMN2 (0.56) HSD17B10HTTTDP1TNFCYP11B1
SCHEMBL239691 0.74 HTT (0.48) HSD17B10ALOX15CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090131369-A1 Novel Benzimidazole(Thio)Carbamates with Antiparasitic Activity and the Synthesis Thereof INTERVET INTERNATIONAL B.V. (NL) 2009-05-21 US disclosed
EP-1913009-A1 NOVEL BENZIMIDAZOLE (THIO) CARBAMATES WITH ANTIPARASITIC ACTIVITY AND THE SYNTHESIS THEREOF Intervet International BV (NL) 2008-04-23 EP disclosed
WO-2007014846-A1 NOVEL BENZIMIDAZOLE (THIO) CARBAMATES WITH ANTIPARASITIC ACTIVITY AND THE SYNTHESIS THEREOF INTERVET INTERNATIONAL B.V. (NL) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131369-A1 Novel Benzimidazole(Thio)Carbamates with Antiparasitic Activity and the Synthesis Thereof CYP2C8, CYP3A7, CYP8B1 HSD17B10 1565/4885ALOX15 1927/4885CYP1A2 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.